38th Annual Miami Breast Cancer Conference® - Abstracts

31 Using a 3D Fiducial Marker System to Advance the Use of 3D Accelerated Partial Breast Irradiation

April 29th 2021

38 Use of MRI as an Additional Breast Imaging Tool in Patients With Pathological Nipple Discharge and Comparative Sensitivity With Ultrasound (5-year retrospective study)

By

April 29th 2021

2 Landscape of Germline Mutations in DNA Repair Genes for Breast Cancer in a Multinational Region Located in the Southeast of the European Part of Russia

April 29th 2021

3 Analysis of Exhaled Volatile Organic Compounds: A New Frontier in Breast Cancer Screening and Surveillance

By

April 29th 2021

15 TiP The FLEX Real-World Data Platform Explores New Gene Expression Profiles and Investigator-Initiated Protocols in Early-Stage Breast Cancer

April 29th 2021

16 Improving Electronic Medical Record (EMR) Documentation of Genomic Test Scores for Patients With Breast Cancer

April 29th 2021

32 Triple-Negative Breast Cancer and Pathological Complete Response: A Study of Racial Disparities

By

April 27th 2021

34 Demographics, Clinical Characteristics, and Treatment Patterns for Patients With BRCA-Mutated, HER2-Negative Early-Stage Breast Cancer: a CancerLinQ Real-World US Study

By

April 27th 2021

39 Delay in Presentation and Management of Patients With Breast Cancer in Baghdad, Iraq

April 27th 2021

47 A Biomarker Assay Predicts Women Diagnosed With DCIS Without Microinvasion Are at Increased Risk for Breast Cancer– Specific Death

By

April 22nd 2021

48 TiP - The PREDICT Registry: A Prospective Registry Study to Evaluate the Effect of a Predictive Assay on Treatment Decisions in Patients With DCIS Following Breast- Conserving Therapy

April 22nd 2021

55 - BC200 RNA Changes in Breast Cancer Patients After Treatment

By

April 22nd 2021

Trending on CancerNetwork

Which Lung Cancer Presentations Will Move the Needle at WCLC 2026?

Double-Dose Gadopiclenol Improves Detection of Small Brain Metastases

What Needs to Happen Before Menin Inhibitors Move Into Frontline AML Combinations?

Ensartinib Treatment for Rare Nonclassical ALK Fusion Lung Adenocarcinoma With Brain Metastasis

Early Camizestrant Is Favored Upon ESR1 Mutation Emergence in Breast Cancer